Chronic myeloproliferative disorders. The new WHO classification;Chronische myeloproliferative systemerkrankungen: Die neue WHO-klassifikation

Pathologe

Volumn 22, Issue 6, 2001, Pages 429-443

  Thiele, J ^a   Kvasnicka, H M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chronic myeloproliferative disorders; Clinical findings; Differential diagnosis; Histopathology; Prognostic parameters; WHO classification

Indexed keywords

CORRELATION FUNCTION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MYELOPROLIFERATIVE DISORDER; PROGNOSIS; REVIEW; SURVIVAL; WORLD HEALTH ORGANIZATION;

BONE MARROW; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; PROGNOSIS; THROMBOCYTHEMIA, HEMORRHAGIC; WORLD HEALTH ORGANIZATION;

EID: 0035175519     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920100492     Document Type: Review

References (136)

1. Prognostic significance of bone marrow biopsy in essential thrombocythemia
2. Juvenile myelomonocytic leukemia
3. Megakaryoblastic leukemia presenting as acute myelofibrosis - A study of four cases with the platelet-peroxidase reaction
4. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome
5. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders
6. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
7. The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia
8. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD)
9. Acute ("malignant") myelosclerosis
10. The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia
11. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols
12. Polycythemia rubra vera
13. The 5q syndrome
14. Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia
15. The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia
16. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts
17. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification
18. Chronic myeloproliferative disorders (CMPD)
19. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia
20. Iron stores in chronic granulocytic leukaemia at presentation
21. Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia
22. An assessment of the clinicohematological criteria for the accelerated phase of chronic myeloid leukemia
23. The changing profile of idiopathic myelofibrosis: A comparison of the presenting features of patients diagnosed in two different decades
24. High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel
25. Essential thrombocythemia: A retrospective study on the clinical course of 100 patients
26. The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature
27. Allografting for chronic myeloid leukaemia
28. Chronic myelogenous leukemia: A review
29. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia
30. The molecular biology of chronic myeloid leukemia
31. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia
32. Megakaryoblastic leukaemia (acute myelofibrosis): A report of three cases
33. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes
34. Hematopathologic findings in the myeloproliferative disorders
35. Unrelated donor marrow transplantation for chronic myelogenous leukaemia
36. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
37. Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system
38. The bone marrow in polycythemia vera
39. Chronic myelogenous leukemia: Biology and therapy
40. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia
41. Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia
42. Chronic myeloproliferative disorders in bone marrow biopsies
43. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies
44. The histopathology of chronic myeloproliferative diseases
45. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
46. Thrombocytosis with sideroblastic erythropoiesis: A mixed myeloproliferative myelodysplastic syndrome
47. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
48. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa
49. Chronic neutrophil leukaemia in adolescence and young adulthood
50. Acquired lipidosis of marrow macrophages: Birefringent blue crystals and Gaucher-like cells, sea-blue histiocytes, and grey-green crystals
51. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia
52. Current aspects of drug therapy in Philadelphia-positive CML: Correlation of tumor burden with survival
53. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia
54. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis
55. Essential thrombocythemia at diagnosis: Causes of diagnostic evaluation and presence of positive diagnostic findings
56. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications
57. Megakaryocytes in chronic myeloproliferative disorders: Numerical density correlated between different entities
58. Chronic myelogenous leukemia: A multivariate analysis of the associations of patient characteristics and therapy with survival
59. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients
60. Characteristics of accelerated disease in chronic myelogenous leukemia
61. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy
62. Sea-blue histiocytes and Gaucher cells in bone marrow of patients with chronic myeloid leukaemia
63. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia
64. 5q-syndrome presenting as essential thrombocythemia: Myelodysplastic syndrome or chronic myeloproliferative disorders?
65. Prognostic factors in idiopathic (primary) osteomyelofibrosis
66. Prognostic impact of apoptosis and proliferation in idiopathic (primary) myelofibrosis
67. Prognostische faktoren und überlebenszeiten bei chronischen myeloproliferativen erkrankungen (CMPE)
68. 1+ chronic myelogenous leukaemia - A multicentre study on 495 patients
69. 1+ chronic myelogenous leukemia: A multicenter trial
70. Myelodysplastic syndrome associated with bone marrow fibrosis
71. Myelofibrosis in chronic granulocytic leukaemia: Clinicopathologic correlations and prognostic significance
72. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia
73. 9/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages
74. Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients
75. + CML and chronic myelomonocytic leukemia
76. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders
77. Myelofibrosis in primary myelodysplastic syndromes: A retrospective study of 352 patients
78. The 5q syndrome: A single-institution study of 43 consecutive patients
79. Age and sex distributions of hematological malignancies in the U.K.
80. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted County study, 1976-1995
81. Low serum erythropoietin - A strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels
82. Diagnosis of polycythaemia
83. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group
84. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
85. Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma
86. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
87. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia
88. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders
89. Pure erythrocytosis: Reappraisal of a study of 51 cases
90. Mixed myelodysplastic and myeloproliferative syndromes
91. Anagrelide, a selective thrombocytopenic agent
92. A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia
93. Neutrophilic-chronic myeloid leukemia: A distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)
94. Spontaneous erythroid colony formation in the differential diagnosis of erythrocytosis
95. The course and complications of idiopathic erythrocytosis
96. Diagnosis and classification of erythrocytoses and thrombocytoses
97. Anagrelide, a novel platelet lowering option in essential thrombocythaemia: Treatment experience in 48 patients in Germany
98. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases
99. Is the histological classification of chronic granulocytic leukaemia justified from the clinical point of view?
100. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders
101. Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival
102. 9/L
103. Chronic myeloid leukemia
104. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology
105. Polycythemia vera, 1935-1969: An epidemiologic survey in Rochester, Minnesota
106. Decreased stainable marrow iron in chronic granulocytic leukemia
107. Staging and prognosis in chronic myelogenous leukemia
108. Primary thrombocythemia
109. Myelofibrosis with myeloid metaplasia
110. Malignant (acute) myelosclerosis myeloscierosis - A clinical and pathological study in 6 patients
111. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - Features of significance for the diagnosis of primary (essential) thrombocythaemia
112. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia) - Correlations between clinical and morphological features
113. Agnogenic myeloid metaplasia (AMM) - Correlation of bone marrow lesions with laboratory data: A longitudinal clinico-pathological study on 114 patients
114. Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): An immunomorphometric study of bone marrow trephine biopsy specimens
115. Idiopathic primary osteo-myelofibrosis: A clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact
116. Impact of clinical and morphological variables in classification and regression tree-based survival (CART) analysis of CML with special emphasis on dynamic features
117. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - A clinicopathological study
118. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immuno-staining from bone marrow biopsies
119. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - Aids to diagnosis and classification
120. Bone marrow histopathology in chronic myelogenous leukemia (CML) - Evaluation of distinctive features with clinical impact
121. Histologische und hämatologische befunde bei der CML. Eine immunhistochemisch-morphometrische und klinische vergleichsstudie an beckenkammbiopsien von 604 patienten aus zwei Instituten für Pathologie (Köln/Freiburg)
122. Bone marrow features and clinical findings in chronic myeloid leukemia - A comparative, multicenter, immunohistological and morphometric study on 614 patients
123. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis
124. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients
125. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis
126. The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias
127. Primary thrombocythemia: Diagnosis, clinical manifestations and management
128. Chapter 1: Chronic myeloproliferative diseases
129. Myelofibrosis with myeloid metaplasia: Clinical and haematological parameters predicting survival in a series of 133 patients
130. Polycythemia vera. I. Histopathology, ultrastructure and cytogenetics of the bone marrow in comparison with secondary polycythemia
131. The idiopathic hypereosinophilic syndrome
132. Primary polycythaemia: Diagnosis by non-conventional positive criteria
133. Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias
134. Myelofibrosis with myeJoid myeloid metaplasia: Pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly
135. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia
136. Chronic neutrophilic leukemia. A study of four cases